Aurobindo Pharma Limited

Aurobindo Pharma Limited

AUROPHARMA.NS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.05T
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Aurobindo Pharma LimitedAurobindo Pharma Limited26.40.38%10%2.80.2
$1422.39

Current Fair Value

22% downside

Overvalued by 22% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.05 Trillion
Enterprise Value$1.04 Trillion
Annual dividend$7.00
Dividend yield0.38%
Earnings per Share$60.34
Beta0.02
Outstanding Shares575,400,000

Return

Return on Equity10.13%ROE
Return on Assets6.46%
Return on Invested Capital14.40%

Valuation & Multiples

P/E Ratio26.44P/E Ratio
PEG80.8PEG
Price to Sales2.85Price to Sales
Price to Book Ratio2.67Price to Book Ratio
Enterprise Value to Revenue2.81
Enterprise Value to EBIT17.09
Enterprise Value to Net Income25
Total Debt to Enterprise0.08
Debt to Equity0.22Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 14, 2026
EPS Estimate
$19.37
Consensus analyst estimate
Revenue Estimate
$98.24 B
Consensus analyst estimate

Next Earnings Call

Expected Date
February 14, 2027
EPS Estimate
$21.48
Consensus analyst estimate
Revenue Estimate
$103.69 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Aurobindo Pharma Limited

29,209 employees
CEO: Kambam Nithyananda Reddy

Aurobindo Pharma Limited is a global pharmaceutical company specializing in the production of generic formulations and active pharmaceutical ingredients (APIs). Its operations span across India, the United States, Europe, and other inter...